Jacqualyn A. Fouse
2013 - Celgene
In 2013, Jacqualyn A. Fouse earned a total compensation of $7.8M as President Hematology and Oncology at Celgene, a 126% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $3,692,296 |
|---|---|
| Option Awards | $2,269,123 |
| Salary | $753,333 |
| Stock Awards | $1,059,360 |
| Other | $21,829 |
| Total | $7,795,941 |
Fouse received $3.7M in non-equity incentive plan, accounting for 47% of the total pay in 2013.
Fouse also received $2.3M in option awards, $753.3K in salary, $1.1M in stock awards and $21.8K in other compensation.
Rankings
In 2013, Jacqualyn A. Fouse's compensation ranked 661st out of 12,286 executives tracked by ExecPay. In other words, Fouse earned more than 94.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 661 out of 12,286 | 95th |
Division Manufacturing | 215 out of 4,612 | 95th |
Major group Chemicals And Allied Products | 55 out of 1,466 | 96th |
Industry group Drugs | 34 out of 1,160 | 97th |
Industry Pharmaceutical Preparations | 31 out of 890 | 97th |
Source: SEC filing on April 28, 2016.
Fouse's colleagues
We found four more compensation records of executives who worked with Jacqualyn A. Fouse at Celgene in 2013.